Boardroom Alpha
8-K primary document
CTSH · Current Report (Form 8-K) · Filed October 29, 2025

Cognizant Technology Solutions Corp8-K exhibit

exhibit9929302025.htm
exhibit9929302025
Third quarter revenue grew 6.5% year-over-year and 2.8% sequentially in constant currency, representing our fifth consecutive quarter of year-over-year organic revenue growth and our strongest sequential organic growth since 2022. We maintained our large deal momentum, signing six large deals in the quarter, bringing our year-to-date total to 16 with 40% growth in large deal TCV year-to-date compared to the same period last year. I am proud of our year-to- date top-tier revenue growth, which is a testament to our differentiated capabilities at the intersection of technology and industry. We believe our three vector AI builder strategy is gaining traction and we expect our early investments in AI-led platforms and IP on the edge will help power growth in the years ahead. Q3 2025 Ravi Kumar S | Chief Executive Officer ” Revenue $5.4 billion Reported YoY1 é 7.4% Constant Currency YoY1 é 6.5% GAAP and Adjusted Operating Margin | 16.0% GAAP Diluted EPS | $0.56 $4.0 $1.0 $0.4 Rest of World 0.9% Revenue by Geography ($ In billions) Reported YoY | Constant Currency YoY Q3 2025 Cash Flow Cash Flow From Operations $1,227M Free Cash Flow $1,160M Q3 2025 Capital Return Dividends $151M Share Repurchases $463M $0.31/share Revenue by Segment ($ In billions) Reported YoY | Constant Currency YoY Europe North America1 2.6% $1.6 $0.8 $1.4 $1.6 Products & Resources1 Health Sciences Financial Services Communications, Media & Technology 7.8% 2.7% 7.8% 7.8% 4.2% 3.6%12.6% 11.4% 6.2% 5.4%5.9% 5.1% Total Employees 349,800 ” +6,000 QoQ +9,700 YoY Voluntary Attrition - Tech Services (Trailing 12-Month) 14.5% é é é é é é é é é é é Adjusted Diluted EPS | $1.39 Employee Metrics Adjusted Operating Margin | 16.0% é é é 1 In the third quarter of 2025, revenue from our recently completed acquisition of Belcan contributed approximately 2.5 percentage points to year-over-year revenue growth, including approximately 9 percentage points of growth to our Products & Resources segment, primarily in North America and to a lesser extent in the United Kingdom. 2 GAAP Diluted EPS reflects the $0.80 impact from a one-time, non-cash income tax expense. For non-GAAP financial reconciliations refer to Cognizant's 2025 third quarter earnings release issued on October  29, 2025, which accompanies this presentation and is available at investors.cognizant.com. é Company Recognition Recognized as one of Forbes World’s Best Employers Exhibit 99.2 (70) bps QoQ Earned Guinness World Record title for largest online generative AI hackathon Named to TIME World’s Best Companies list GAAP EPS2 | $0.56 Adjusted Diluted EPS | $1.39


 
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer